Detailed text transcripts for TV channel - MSNBC - 20181106:18:42:00
Aromatase inhibitor, which is for postmenopausal women with hormone receptor-positive her2- metastatic breast cancer as the first hormonal based therapy. ibrance plus letrozole was significantly more effective at delaying disease progression versus letrozole. patients taking ibrance can develop low white blood cell counts, which may cause serious infections that can lead to death. before taking ibrance, tell your doctor if you have fever, chills, or other signs of infection, liver or kidney prob...
Breast Cancer Hormone Receptor Ibrance Plus Letrozole Disease Progression Versus Letrozole Aromatase Inhibitor Blood Cell Counts
Source: archive.org